Sep 11, 2024 EU Pharmaceutical Reform: Update on the proposed changes to marketing authorisation procedures By Sally Shorthose Sophie Vo This article is part of our series covering the proposed reforms to the EU pharmaceutical legislation. To view the entire series, click...
Apr 24, 2023 The Netherlands: Tolerance policy on online prescribing of medication now embodied in new policy rule By Emma Stok Hester Borgers On 11 April 2023, the Dutch Ministry of Health, Welfare and Sport announced a new policy rule for the online prescription of medication,...
Feb 02, 2023 Reminder of the key requirements of the anti-gift law following the €1 million+ fine of a pharmaceutical company By Nour Saab Alexandre Vuchot Johanna Harelimana Breach of the “anti-gift” law An investigation by the Directorate General for Fair Trading, Consumer Affairs and Fraud Control (“DGCCRF”)...
Oct 31, 2022 Update on the UK’s future medical device regulations: Extended timelines By Pieter Erasmus The UK’s Medicines & Healthcare products Regulatory Agency (MHRA) has recently announced the introduction of a 12-month extension to the...
May 19, 2022 New Draft Implementing Regulations propose key changes for pharmaceuticals in China By Alison Wong Martoe Xu On 9 May 2022, the National Medical Products Administration (the “NMPA”) published the Implementing Regulations of the Drug...